Cancers | Top 10 Cited Papers in 2023 in the Section “Methods and Technologies Development”
We are pleased to invite you to read the Top 10 Cited Cancers Papers of 2023 (ISSN: 2072-6694) in Section “Methods and Technologies Development”. We hope this announcement will provide useful information for this field.
The list of papers is as follows:
“Multiphysics Modeling of Low-Intensity Pulsed Ultrasound Induced Chemotherapeutic Drug Release from the Surface of Gold Nanoparticles”
by Tyler K. Hornsby, Farshad Moradi Kashkooli, Anshuman Jakhmola, Michael C. Kolios and Jahangir (Jahan) Tavakkoli
Cancers 2023, 15(2), 523; https://doi.org/10.3390/cancers15020523
Available online: https://www.mdpi.com/2072-6694/15/2/523
“New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy”
by Sara C. Freitas, Daniel Sanderson, Sofia Caspani, Ricardo Magalhães, Belén Cortés-Llanos, Andreia Granja, Salette Reis, João Horta Belo, José Azevedo, Maria Victoria Gómez-Gaviro et al.
Cancers 2023, 15(2), 383; https://doi.org/10.3390/cancers15020383
Available online: https://www.mdpi.com/2072-6694/15/2/383
“Hybrid Quantum Neural Network for Drug Response Prediction”
by Asel Sagingalieva, Mohammad Kordzanganeh, Nurbolat Kenbayev, Daria Kosichkina, Tatiana Tomashuk and Alexey Melnikov
Cancers 2023, 15(10), 2705; https://doi.org/10.3390/cancers15102705
Available online: https://www.mdpi.com/2072-6694/15/10/2705
“Thin-Slice Prostate MRI Enabled by Deep Learning Image Reconstruction”
by Sebastian Gassenmaier, Verena Warm, Dominik Nickel, Elisabeth Weiland, Judith Herrmann, Haidara Almansour, Daniel Wessling and Saif Afat
Cancers 2023, 15(3), 578; https://doi.org/10.3390/cancers15030578
Available online: https://www.mdpi.com/2072-6694/15/3/578
“Bispecific Antibodies in Multiple Myeloma: Opportunities to Enhance Efficacy and Improve Safety”
by Dawn Swan, Philip Murphy, Siobhan Glavey and John Quinn
Cancers 2023, 15(6), 1819; https://doi.org/10.3390/cancers15061819
Available online: https://www.mdpi.com/2072-6694/15/6/1819
“PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment”
by Lorenzo Bianchi, Francesco Ceci, Eleonora Balestrazzi, Francesco Costa, Matteo Droghetti, Pietro Piazza, Alessandro Pissavini, Massimiliano Presutti, Andrea Farolfi, Riccardo Mei et al.
Cancers 2023, 15(7), 2027; https://doi.org/10.3390/cancers15072027
Available online: https://www.mdpi.com/2072-6694/15/7/2027
“Within-Modality Synthesis and Novel Radiomic Evaluation of Brain MRI Scans”
by Seyed Masoud Rezaeijo, Nahid Chegeni, Fariborz Baghaei Naeini, Dimitrios Makris and Spyridon Bakas
Cancers 2023, 15(14), 3565; https://doi.org/10.3390/cancers15143565
Available online: https://www.mdpi.com/2072-6694/15/14/3565
“State of the Art MR Imaging for Lung Cancer TNM Stage Evaluation”
by Yoshiharu Ohno, Yoshiyuki Ozawa, Hisanobu Koyama, Takeshi Yoshikawa, Daisuke Takenaka, Hiroyuki Nagata, Takahiro Ueda, Hirotaka Ikeda and Hiroshi Toyama
Cancers 2023, 15(3), 950; https://doi.org/10.3390/cancers15030950
Available online: https://www.mdpi.com/2072-6694/15/3/950
“Modulating T Cell Responses by Targeting CD3”
by Ashwathi Puravankara Menon, Beatriz Moreno, Daniel Meraviglia-Crivelli, Francesca Nonatelli, Helena Villanueva, Martin Barainka, Angelina Zheleva, Hisse M. van Santen and Fernando Pastor
Cancers 2023, 15(4), 1189; https://doi.org/10.3390/cancers15041189
Available online: https://www.mdpi.com/2072-6694/15/4/1189
“Detection Efficacy of 68Ga-PSMA-11 PET/CT in Biochemical Recurrence of Prostate Cancer with Very Low PSA Levels: A 7-Year, Two-Center “Real-World” Experience”
by Caroline Burgard, Manuela A. Hoffmann, Madita Frei, Hans-Georg Buchholz, Fadi Khreish, Robert J. Marlowe, Mathias Schreckenberger, Samer Ezziddin and Florian Rosar
Cancers 2023, 15(5), 1376; https://doi.org/10.3390/cancers15051376
Available online: https://www.mdpi.com/2072-6694/15/5/1376
You are invited to view and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.
Cancers Editorial Office